Gausemycin A-Resistant Staphylococcus aureus Demonstrates Affected Cell Membrane and Cell Wall Homeostasis.
Darya V PoshvinaDiana S DilbaryanAlexey S VasilchenkoPublished in: Microorganisms (2023)
Antibiotic resistance is a significant and pressing issue in the medical field, as numerous strains of infectious bacteria have become resistant to commonly prescribed antibiotics. Staphylococcus aureus is a bacterium that poses a grave threat, as it is responsible for a large number of nosocomial infections and has high mortality rates worldwide. Gausemycin A is a new lipoglycopeptide antibiotic that has considerable efficacy against multidrug-resistant S. aureus strains. Although the cellular targets of gausemycin A have been previously identified, detailing the molecular processes of action is still needed. We performed gene expression analysis to identify molecular mechanisms that may be involved in bacterial resistance to gausemycin A. In the present study, we observed that gausemycin A-resistant S. aureus in the late-exponential phase showed an increased expression of genes involved in cell wall turnover (sceD ), membrane charge ( dltA ), phospholipid metabolism ( pgsA ), the two-component stress-response system (vraS ), and the Clp proteolytic system ( clpX ). The increased expression of these genes implies that changes in the cell wall and cell membrane are essential for the bacterial resistance to gausemycin A. In the stationary phase, we observed a decrease in the expression of genes involved in the phospholipid metabolism ( mprF ) and Clp proteolytic system ( clpX ).
Keyphrases
- cell wall
- staphylococcus aureus
- poor prognosis
- multidrug resistant
- escherichia coli
- genome wide identification
- binding protein
- acinetobacter baumannii
- fatty acid
- long non coding rna
- healthcare
- cardiovascular events
- gene expression
- biofilm formation
- drug resistant
- risk factors
- methicillin resistant staphylococcus aureus
- pseudomonas aeruginosa
- transcription factor
- liquid chromatography
- cardiovascular disease
- type diabetes
- postmenopausal women
- genome wide analysis